関連する実験動画

Updated: Apr 23, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

38.2K

感染症. 感染症. エボラウイルス対策が失敗すると

Jon Cohen

    Science (New York, N.Y.)
    |October 4, 2014
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    23.0K
    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
    09:04

    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

    Published on: May 11, 2020

    12.7K

    関連する実験動画

    Last Updated: Apr 23, 2026

    Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
    10:11

    Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

    Published on: September 27, 2014

    38.2K
    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    23.0K
    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
    09:04

    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

    Published on: May 11, 2020

    12.7K

    関連する概念動画

    Cross-reactivity00:42

    Cross-reactivity

    28.7K
    Overview
    28.7K
    Vaccinations01:51

    Vaccinations

    43.7K
    Overview
    43.7K
    Vaccine Production01:23

    Vaccine Production

    120
    Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
    120
    Vaccines01:21

    Vaccines

    64
    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
    64
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    JoVEについて
    概要リーダーシップブログJoVEヘルプセンター
    著者向け
    出版プロセス編集委員会範囲と方針査読よくある質問投稿
    図書館員向け
    推薦の声購読アクセスリソース図書館諮問委員会よくある質問
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
    利用規約
    プライバシーポリシー
    ポリシー
    Jove
    Visualize
    お問い合わせ